Literature DB >> 21962493

Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function.

Song Gao1, Alexander von der Malsburg, Alexej Dick, Katja Faelber, Gunnar F Schröder, Otto Haller, Georg Kochs, Oliver Daumke.   

Abstract

Human myxovirus resistance protein 1 (MxA) is an interferon-induced dynamin-like GTPase that acts as a cell-autonomous host restriction factor against many viral pathogens including influenza viruses. To study the molecular principles of its antiviral activity, we determined the crystal structure of nucleotide-free MxA, which showed an extended three-domain architecture. The central bundle signaling element (BSE) connected the amino-terminal GTPase domain with the stalk via two hinge regions. MxA oligomerized in the crystal via the stalk and the BSE, which in turn interacted with the stalk of the neighboring monomer. We demonstrated that the intra- and intermolecular domain interplay between the BSE and stalk was essential for oligomerization and the antiviral function of MxA. Based on these results, we propose a structural model for the mechano-chemical coupling in ring-like MxA oligomers as the principle mechanism for this unique antiviral effector protein.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21962493     DOI: 10.1016/j.immuni.2011.07.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  96 in total

Review 1.  Building a fission machine--structural insights into dynamin assembly and activation.

Authors:  Joshua S Chappie; Fred Dyda
Journal:  J Cell Sci       Date:  2013-06-18       Impact factor: 5.285

Review 2.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

3.  Human MxB Protein Is a Pan-herpesvirus Restriction Factor.

Authors:  Mirjam Schilling; Lorenzo Bulli; Sebastian Weigang; Laura Graf; Sebastian Naumann; Corinna Patzina; Valentina Wagner; Liane Bauersfeld; Caroline Goujon; Hartmut Hengel; Anne Halenius; Zsolt Ruzsics; Torsten Schaller; Georg Kochs
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  MxB/Mx2: the latest piece in HIV's interferon puzzle.

Authors:  Oliver T Fackler; Oliver T Keppler
Journal:  EMBO Rep       Date:  2013-11-01       Impact factor: 8.807

Review 5.  Function and regulation of the divisome for mitochondrial fission.

Authors:  Felix Kraus; Krishnendu Roy; Thomas J Pucadyil; Michael T Ryan
Journal:  Nature       Date:  2021-02-03       Impact factor: 49.962

Review 6.  Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.

Authors:  Peter Staeheli; Otto Haller
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

7.  Contribution of MxB oligomerization to HIV-1 capsid binding and restriction.

Authors:  Cindy Buffone; Bianca Schulte; Silvana Opp; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

8.  Structural insights into oligomerization and mitochondrial remodelling of dynamin 1-like protein.

Authors:  Chris Fröhlich; Stefan Grabiger; David Schwefel; Katja Faelber; Eva Rosenbaum; Jason Mears; Oliver Rocks; Oliver Daumke
Journal:  EMBO J       Date:  2013-04-12       Impact factor: 11.598

9.  Genotype frequency contributions of Mx1 gene in eight chicken breeds under different selection pressures.

Authors:  Jingjing Li; Chaowu Yang; Jinshan Ran; Xiaosong Jiang; Huarui Du; Zhiqiang Li; Yiping Liu; Long Zhang
Journal:  3 Biotech       Date:  2018-11-14       Impact factor: 2.406

10.  Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication.

Authors:  Daniel Degrandi; Elisabeth Kravets; Carolin Konermann; Cornelia Beuter-Gunia; Verena Klümpers; Sarah Lahme; Eva Rasch; Anne K Mausberg; Sandra Beer-Hammer; Klaus Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.